Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (8)

2023

  1. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2021

  1. Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes

    International Journal of Clinical Practice, Vol. 75, Núm. 8

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2009

  1. Budlein A from Viguiera robusta inhibits leukocyte-endothelial cell interactions, adhesion molecule expression and inflammatory mediators release

    Phytomedicine, Vol. 16, Núm. 10, pp. 904-915

2008

  1. Leukotriene B4-loaded microspheres: A new therapeutic strategy to modulate cell activation

    BMC Immunology, Vol. 9

  2. Prostaglandin E2-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, Núm. 3, pp. 784-790

2007

  1. A critical role for TNFα in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles

    Blood, Vol. 110, Núm. 6, pp. 1895-1902

  2. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability

    British Journal of Pharmacology, Vol. 152, Núm. 4, pp. 481-492